Cargando…

The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight

Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. Although therapeutic strategies have recently advanced, tumor metastasis and drug resistance continue to pose challenges in the treatment of HCC. Therefore, new molecular targets are needed to develop novel therape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tongyue, Liu, Danfei, Wang, Yijun, Sun, Mengyu, Xia, Limin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873604/ https://www.ncbi.nlm.nih.gov/pubmed/33585247 http://dx.doi.org/10.3389/fonc.2020.620352

Ejemplares similares

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021)

ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Liu, Danfei, et al.
Publicado: (2021)

Correction to: ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Liu, Danfei, et al.
Publicado: (2021)

Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation
por: He, Qin, et al.
Publicado: (2021)

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET
por: Zhang, Tongyue, et al.
Publicado: (2022)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

The Centrality of Obesity in the Course of Severe COVID-19
por: Liu, Danfei, et al.
Publicado: (2021)

Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
por: Wang, Yijun, et al.
Publicado: (2021)

Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy
por: Luo, Xiangyuan, et al.
Publicado: (2022)

The roles of nausea and vomiting in COVID-19: did we miss something?
por: Zhang, Tongyue, et al.
Publicado: (2021)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2
por: Xie, Meng, et al.
Publicado: (2022)

Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention
por: Feng, Yangyang, et al.
Publicado: (2021)

A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression
por: Mafi, Alireza, et al.
Publicado: (2023)

m(6)A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R
por: Qiao, Chenyang, et al.
Publicado: (2021)

HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
por: Liu, Danfei, et al.
Publicado: (2022)

FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter
por: Lin, Zhuoying, et al.
Publicado: (2021)

CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3
por: Feng, Weibo, et al.
Publicado: (2021)

Circulating tumor DNA moves further into the spotlight
por: Sausen, Mark, et al.
Publicado: (2014)

Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma
por: Li, Shuang, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Luo, Jia, et al.
Publicado: (2022)

Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight
por: Hopp, Ann-Katrin, et al.
Publicado: (2021)

A spotlight on alkaloid nanoformulations for the treatment of lung cancer
por: S. M., Sindhoor, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets
por: Ding, Ziyang, et al.
Publicado: (2023)

Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy
por: Humbert, Olivier, et al.
Publicado: (2020)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Ketogenic Diets and Hepatocellular Carcinoma
por: Lan, Yan, et al.
Publicado: (2022)

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020)

Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review
por: Wang, Caizheng, et al.
Publicado: (2023)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Case Report: Toripalimab Combined With Anlotinib in a Patient With Metastatic Upper Tract Urothelial Carcinoma After Pembrolizumab Failure
por: Zan, Ning, et al.
Publicado: (2022)

C-Reactive Protein Is an Indicator of the Immunosuppressive Microenvironment Fostered by Myeloid Cells in Hepatocellular Carcinoma
por: Wang, Yongchun, et al.
Publicado: (2022)

Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma
por: Zhou, Pengcheng, et al.
Publicado: (2021)

RHO GTPase family in hepatocellular carcinoma
por: Wang, Tiantian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qttsn49qsreenc9aj7fv9dda0r